Hidac: Clinical Trials

2 trials of Hidac, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Terminated 1

Follow Hidac: new trials by email Literature Review of Hidac trials Research Report on Hidac

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Cytarabine consolidation, Allogeneic transplant - Acute Myeloid Leukemia
Phase 2 / Phase 3TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins102013-12-012018-08-14
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection - Peripheral T-Cell Lymphoma
Phase 2TerminatedUniversity of California, San Francisco212008-07-012020-04-27

Conditions studied

Leukemia, Myeloid, Acute (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University of California, San Francisco (1)

Countries

United States (2)

Top investigators

Lawrence Kaplan, MD (1)  ·  Margaret Showel, MD (1)